Skip to main content

Skin Cancer News (Page 2)

Related terms: Cancer, Skin

FDA Approves New Treatment for Advanced Melanoma, Amtagvi

MONDAY, Feb. 19, 2024 – The U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer. Amtagvi, made by Iovance Biotherapeutics...

Gender Minority Adults Are Vulnerable During Full Body Skin Exam

FRIDAY, Feb. 2, 2024 – Within the sexual and gender minority (SGM) population, gender minority adults are more likely to report discomfort during full body skin examinations (FBSEs), according to a...

FDA Approves AI Device That Helps Spot Skin Cancer

THURSDAY, Jan. 18, 2024 (HealthDay news) – The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug...

Risk for Skin Cancer Increased for Patients With Lower Extremity Lymphedema

MONDAY, Dec. 18, 2023 – Patients with lower extremity (LE) lymphedema have an increased risk for skin cancer, especially basal cell carcinoma, according to a study published online in the November...

AI Accurate in Diagnosing Suspicious Skin Lesions

WEDNESDAY, Nov. 29, 2023 – A mobile phone-powered artificial intelligence (AI) technology is effective for diagnosing suspicious skin lesions, according to a study published in the October issue...

Occupational Exposure to Solar UVR Linked to Nonmelanoma Skin Cancer

MONDAY, Nov. 20, 2023 – Occupational exposure to solar ultraviolet radiation (UVR) is associated with a substantial burden of nonmelanoma skin cancer (NMSC), according to a study published in the...

Derm Dangers: Avoid These 5 Unhealthy Skin Care Trends

WEDNESDAY, Nov. 15, 2023 – Social media platforms are spouting a steady stream of unsafe skin care trends, according to the American Academy of Dermatology. This is National Healthy Skin Month, and...

UN Report Warns That Working in the Sun Causes Skin Cancers

THURSDAY, Nov. 9, 2023 (Healthday News) – New data from two United Nations agencies shows that millions of workers toiling under the sun's glare is fueling skin cancer cases around the world. Nearly...

AI Getting Better at Detecting Skin Cancer

FRIDAY, Nov. 3, 2023 – Artificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and...

Skin Diseases Pose a Psychosocial Burden

THURSDAY, Nov. 2, 2023 – Skin diseases can cause a psychosocial burden and feelings of stigmatization, according to a study published online Oct. 8 in the Journal of the European Academy of ...

Latest AI Has 100% Success Rate in Spotting Melanomas

FRIDAY, Oct. 13, 2023 – The ability to detect skin cancer using artificial intelligence (AI) software has rapidly improved. New research presented Wednesday at a medical conference in Berlin shows...

Increased Exposure to PFAS, Phenols Linked to Prior Cancer Diagnosis

MONDAY, Sept. 25, 2023 – Per- and polyfluoroalkyl substances (PFAS), phenols, and parabens are associated with a previous cancer diagnosis, according to a study published online Sept. 18 in the...

FDA Approves Libtayo (cemiplimab-rwlc) for Advanced Cutaneous Squamous Cell Carcinoma

September 28, 2018 – The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous...

FDA Approves Mektovi (binimetinib) and Braftovi (encorafenib) in Combination for Unresectable or Metastatic Melanoma with BRAF Mutations

On June 27, 2018, the Food and Drug Administration approved encorafenib and binimetinib (Braftovi and Mektovi, Array BioPharma Inc.) in combination for patients with unresectable or metastatic...

Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations

BOULDER, Colo., June 27, 2018 /PRNewswire/ – Array BioPharma Inc. (Nasdaq: ARRY) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi capsules in combination with...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Basal Cell Carcinoma, Melanoma, Cancer

Related drug support groups

Efudex